NCT02093260View on ClinicalTrials.gov

Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

405

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2014

Conditions

Healthy

Interventions

BIOLOGICAL

Vaccine

"Flubio (Influenza HA) Vaccine~The vaccine will be given intramuscularly."

Trial Locations (2)

Unknown

Jatinegara Primary Health Center, Jakarta

Primary School of SDN 01 Kampung Melayu, Jakarta

Sponsors

Lead Sponsor

All Listed Sponsors

lead

PT Bio Farma

INDUSTRY